ES is well characterized at the molecular level and is mainly defined by recurring translocations that generate oncogenic gene fusions involving the FET gene family (EWSR1, FUS, TAF15) as 5′ gene fusion partners, with EWSR1 being the common partner in most cases. The gene discussed is EWSR1; the disease is Ewing sarcoma.